MET and lung sarcomatoid carcinoma: Sarcomatoid carcinoma in the lung may be associated with two important molecular groups: one cluster is triggered by tobacco and typically involves RAS mutations, the MAPK pathway, and PD-L1 positivity; the other cluster is usually associated with targetable molecular alterations such as c-met [41].